IgM amyloidosis: Clinical features in therapeutic outcomes

Morie A. Gertz; Francis K. Buadi; Suzanne R. Hayman

doi:10.3816/CLML.2011.n.034

IgM amyloidosis: Clinical features in therapeutic outcomes

Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman

Hematology

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

It is not widely recognized that patients with amyloidosis may be associated with an IgM monoclonal protein. We reviewed the characteristics of 22 IgM amyloidosis patients seen at Mayo Clinic from 1989 through 2010 and uniformly treated with stem cell transplantation. IgM patients are older, have a higher prevalence of neuropathy, a lower incidence of cardiac involvement (lower troponin T and NT-proBNP), and a much lower level of the involved immunoglobulin free light chain.

Original language	English (US)
Pages (from-to)	146-148
Number of pages	3
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	11
Issue number	1
DOIs	https://doi.org/10.3816/CLML.2011.n.034
State	Published - Feb 1 2011

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3816/CLML.2011.n.034

Cite this

@article{7ca4175f6f39441a833f6ccc4a4b94af,

title = "IgM amyloidosis: Clinical features in therapeutic outcomes",

abstract = "It is not widely recognized that patients with amyloidosis may be associated with an IgM monoclonal protein. We reviewed the characteristics of 22 IgM amyloidosis patients seen at Mayo Clinic from 1989 through 2010 and uniformly treated with stem cell transplantation. IgM patients are older, have a higher prevalence of neuropathy, a lower incidence of cardiac involvement (lower troponin T and NT-proBNP), and a much lower level of the involved immunoglobulin free light chain.",

author = "Gertz, {Morie A.} and Buadi, {Francis K.} and Hayman, {Suzanne R.}",

year = "2011",

month = feb,

day = "1",

doi = "10.3816/CLML.2011.n.034",

language = "English (US)",

volume = "11",

pages = "146--148",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Cancer Media Group",

number = "1",

}

TY - JOUR

T1 - IgM amyloidosis

T2 - Clinical features in therapeutic outcomes

AU - Gertz, Morie A.

AU - Buadi, Francis K.

AU - Hayman, Suzanne R.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - It is not widely recognized that patients with amyloidosis may be associated with an IgM monoclonal protein. We reviewed the characteristics of 22 IgM amyloidosis patients seen at Mayo Clinic from 1989 through 2010 and uniformly treated with stem cell transplantation. IgM patients are older, have a higher prevalence of neuropathy, a lower incidence of cardiac involvement (lower troponin T and NT-proBNP), and a much lower level of the involved immunoglobulin free light chain.

AB - It is not widely recognized that patients with amyloidosis may be associated with an IgM monoclonal protein. We reviewed the characteristics of 22 IgM amyloidosis patients seen at Mayo Clinic from 1989 through 2010 and uniformly treated with stem cell transplantation. IgM patients are older, have a higher prevalence of neuropathy, a lower incidence of cardiac involvement (lower troponin T and NT-proBNP), and a much lower level of the involved immunoglobulin free light chain.

UR - http://www.scopus.com/inward/record.url?scp=79953689308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953689308&partnerID=8YFLogxK

U2 - 10.3816/CLML.2011.n.034

DO - 10.3816/CLML.2011.n.034

M3 - Article

C2 - 21454218

AN - SCOPUS:79953689308

SN - 2152-2650

VL - 11

SP - 146

EP - 148

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

IS - 1

ER -

IgM amyloidosis: Clinical features in therapeutic outcomes

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this